Michael Scolaro

Michael Scolaro

Oct 16, 2017

Group 6 Copy 31
-1
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    A randomized and controlled trial to examine the impact of lingual frenotomy on bottle feeding mechanics

    Some babies are born with tongue-tie where an unusually short or tight band of tissue tethers the bottom...

    Dicty World Race - finding the fastest and smartest Dicty cells

    On May 16, Dicty and HL60 cells will race for the "fastest &smartest" title. Both cell types are models...

    Thermal and Fluid Dynamical Effects on the Efficiency of Hyperpolarized Xenon Production

    The American Lung Association estimates that 32 million Americans are affected by lung diseases, many of...

    Backer Badge Funded